New MRI scan could help surgeons avoid facial nerve damage during brain tumor removal
NCT ID NCT04057976
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tested a special MRI technique called diffusion tensor tractography (DTT) to map the facial nerve before surgery for vestibular schwannoma, a benign brain tumor. The facial nerve is at risk during surgery, and injury can cause permanent facial weakness. The study involved 38 adults scheduled for surgery, who received an extra 10-minute MRI scan. Researchers compared the nerve position seen on the MRI with what surgeons found during the operation to see how accurate the technique was.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- probabilistic diffusion tensor tractography (DTT) MRI sequence
- What this could lead to
- If successful, this MRI technique could help surgeons see the facial nerve before operating, potentially reducing the chance of permanent facial weakness.
- What could go wrong
- This is a small, completed study with only 38 participants. The technique may not be reliable enough for routine use, and results need confirmation in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VESTIBULAR SCHWANNOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
King's College Hospital NHS Foundation Trust
London, London, SE5 9RS, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a precise radiation beam spare balance? a study investigates
- Smart sensors could predict falls in older adults with dizziness
- New platform trial takes on NF2 tumors with multiple drug strategies
- Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
- Drug combo aims to shrink NF2 tumors and save hearing
- New hope for acoustic neuroma: direct brain infusion of avastin in early trial